As one of the most frequently mutated oncogenic pathways, PI3K/AKT signaling has been identified to exhibit a broad mutational spectrum on various components, leading to hyperactivation of this pathway to promote tumor development and disease progression [17,18,19,20,21,22]. This evidence concerns the gene PIK3CA and neoplasm.